Our proprietary library of polyenolic zinc-binding agents resolve inflammation through normalization of elevated levels and activity of matrix metalloproteinases (MMPs) and pro-inflammatory mediators.
Our proprietary polyenolic zinc-binding agents resolve inflammation through pleiotropic modulation of pathologically elevated matrix metalloproteinases (MMPs) and pro-inflammatory mediators.